Literature DB >> 20702841

Growth in cerebral palsy.

Morag J Andrew1, Peter B Sullivan.   

Abstract

Cerebral palsy is often accompanied by abnormalities of growth and nutrition; children with severe motor impairments are most at risk. Nutrition, neurological, and endocrine factors all contribute to suboptimal growth. Poor growth and nutrition are associated with poor general health outcomes and reduced levels of participation, and therefore warrant careful evaluation and appropriate intervention. The lack of normative data combined with the complex interaction of nutrition and nonnutrition factors contributing to growth in this population present real difficulties in management. Particular care is needed to avoid overfeeding and the resultant increase in fat mass and associated morbidity.

Entities:  

Mesh:

Year:  2010        PMID: 20702841     DOI: 10.1177/0884533610374061

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  5 in total

1.  Weight Status in the First 2 Years of Life and Neurodevelopmental Impairment in Extremely Low Gestational Age Newborns.

Authors:  Mandy B Belfort; Karl C K Kuban; T Michael O'Shea; Elizabeth N Allred; Richard A Ehrenkranz; Stephen C Engelke; Alan Leviton
Journal:  J Pediatr       Date:  2015-10-21       Impact factor: 4.406

2.  Efficacy of Selective Dorsal Rhizotomy and Intrathecal Baclofen Pump in the Management of Spasticity.

Authors:  Pramath Kakodkar; Hidy Girgis; Perla Nabhan; Sharini Sam Chee; Albert Tu
Journal:  Adv Tech Stand Neurosurg       Date:  2022

3.  Growth and nutritional risk in children with developmental delay.

Authors:  C Malone; F Sharif; C Glennon-Slattery
Journal:  Ir J Med Sci       Date:  2015-11-16       Impact factor: 1.568

4.  Food Habits, Dietary Intake, and Body Composition in Children with Cerebral Palsy.

Authors:  Hyo-Jung Kim; Ha-Neul Choi; Jung-Eun Yim
Journal:  Clin Nutr Res       Date:  2018-10-29

Review 5.  Vitamin D deficiency in children with cerebral palsy: A narrative review of epidemiology, contributing factors, clinical consequences and interventions.

Authors:  Kamel Awadh Alenazi
Journal:  Saudi J Biol Sci       Date:  2021-12-16       Impact factor: 4.052

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.